Answers are grounded in this paper and cite their sources.
Chronic inflammation within the prostate tumor microenvironment drives disease progression, in part because locally released cytokines make malignant cells more motile and better able to invade surrounding tissue. Plant-derived bioactive compounds may offer a potential strategy for attenuating inflammation-associated tumor aggressiveness. This study investigated the effects of the ethyl acetate fraction of Terminalia chebula Retz. (TC-EA) and its major constituent, chebulagic acid, on inflammation-stimulated migration and the invasion of castration-resistant prostate cancer (CRPC) cells. TC-EA was obtained by solvent-partitioning and chemically characterized using the Folin–Ciocalteu method and high-performance liquid chromatography. DU145 and PC3 cells were pretreated with TC-EA or chebulagic acid and subsequently exposed to conditioned medium derived from LPS-exposed THP-1 M1-like macrophages (M1-THP-1-CM), which contained elevated levels of IL-6 and IL-1β. Cell migration and invasion were assessed using wound-healing and Transwell invasion assays, respectively, while gelatin zymography, RT-qPCR, and Western blotting were used to evaluate invasion-associated molecular changes. TC-EA contained 511.12 ± 33.02 mg GAE/g extract of total phenolics and 264.34 ± 13.26 mg/g extract of chebulagic acid. M1-THP-1-CM significantly enhanced the migration and invasion in both cell lines, whereas neutralization of IL-6 or IL-1β attenuated these effects. TC-EA (10–40 μg/mL) and chebulagic acid (5–20 µM) significantly reduced M1-THP-1-CM-enhanced migration and invasion (p < 0.05). These effects were associated with reduced MMP-2 and MMP-9 activities, decreased expression of the invasion-associated proteins uPA, uPAR, and MT1-MMP, increased E-cadherin expression, and decreased N-cadherin and MT1-MMP mRNA expression (p < 0.01), and attenuated phosphorylation of AKT and GSK3β. These findings suggest that TC-EA and chebulagic acid may attenuate inflammation-driven migration and invasion of CRPC cells, potentially involving modulation of cytokine-associated AKT/GSK3β signaling.
No takes yet. Share an insight, caveat, or question.
Srisawad et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: